PharVision Advisers »

Proto Labs shares owned by PharVision Advisers

Quarter-by-quarter ownership of Proto Labs (PRLB) shares owned by PharVision Advisers from 13F filings

Historical chart of PharVision Advisers investment in Proto Labs

Tip: Access up to 7 years of quarterly data

All positions including Proto Labs held by PharVision Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Proto Labs by PharVision Advisers

Quarter filed Position value Share count Share price at filing
2024-12-31 $257k 6.6k 39.09

More positions owned by PharVision Advisers

Wayfair Cl A (W)
ExlService Holdings (EXLS)
Up Fintech Hldg Sponsored Ads (TIGR)
Array Technologies Com Shs (ARRY)
Sprouts Fmrs Mkt (SFM)
Corporacion Amer Arpts S A (CAAP)
Vertiv Holdings Com Cl A (VRT)
Zevra Therapeutics Com New (ZVRA)
Bowhead Specialty Hldgs Com Shs (BOW)
Lexinfintech Hldgs Adr (LX)
Euronet Worldwide (EEFT)
Rigel Pharmaceuticals (RIGL)
Masimo Corporation (MASI)
LSB Industries (LXU)
Bright Horizons Fam Sol In D (BFAM)

View all positions for PharVision Advisers

Top funds holding Proto Labs

BlackRock
Vanguard Group
Disciplined Growth Investors
Dimensional Fund Advisors
State Street Corporation
Rubric Capital Management
Geode Capital Management
Renaissance Technologies
Arrowstreet Capital, Limited Partnership
Morgan Stanley
D. E. Shaw & Co
Charles Schwab Investment Management
Nuveen
S Squared Technology
Luke P. La Valle, Jr.

View all funds holding Proto Labs